Tidal Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.6M Buy
708,717
+567,716
+403% +$33.1M 0.09% 200
2025
Q4
$7.52M Buy
141,001
+35,412
+34% +$1.7M 0.02% 536
2025
Q3
$4.76M Sell
105,589
-27,973
-21% -$1.31M 0.01% 604
2025
Q2
$6.18M Buy
133,562
+52,263
+64% +$2.57M 0.04% 419
2025
Q1
$4.96M Sell
81,299
-8,898
-10% -$519K 0.04% 409
2024
Q4
$5.1M Sell
90,197
-35,153
-28% -$1.96M 0.04% 414
2024
Q3
$6.49M Sell
125,350
-19,338
-13% -$907K 0.07% 275
2024
Q2
$6.01M Buy
144,688
+60,487
+72% +$2.71M 0.08% 230
2024
Q1
$4.55M Sell
84,201
-10,529
-11% -$536K 0.08% 260
2023
Q4
$4.86M Buy
94,730
+24,089
+34% +$1.26M 0.11% 152
2023
Q3
$4.1M Buy
70,641
+12,992
+23% +$796K 0.12% 157
2023
Q2
$3.69M Buy
57,649
+5,532
+11% +$371K 0.11% 181
2023
Q1
$3.61M Sell
52,117
-13,505
-21% -$953K 0.12% 170
2022
Q4
$4.72M Buy
65,622
+2,445
+4% +$184K 0.18% 118
2022
Q3
$4.49M Buy
63,177
+8,962
+17% +$650K 0.19% 104
2022
Q2
$4.17M Sell
54,215
-17,696
-25% -$1.35M 0.15% 120
2022
Q1
$5.25M Buy
71,911
+10,734
+18% +$721K 0.16% 110
2021
Q4
$3.81M Buy
61,177
+19,270
+46% +$1.13M 0.12% 137
2021
Q3
$2.5M Buy
41,907
+12,232
+41% +$806K 0.09% 153
2021
Q2
$1.97M Sell
29,675
-3
-0% -$196 0.08% 168
2021
Q1
$1.87M Buy
29,678
+8,437
+40% +$525K 0.09% 118
2020
Q4
$1.32M Buy
+21,241
New +$1.31M 0.09% 117
2020
Q3
Sell
-13,311
Closed -$783K 248
2020
Q2
$783K Buy
13,311
+8,275
+164% +$495K 0.11% 113
2020
Q1
$281K Sell
5,036
-2,945
-37% -$180K 0.08% 174
2019
Q4
$512K Buy
+7,981
New +$457K 0.22% 99

Other funds holding BMY

Tidal Investments's BMY Position: Q1 2026 in Review

Tidal Investments increased its Bristol-Myers Squibb (BMY) stake by 403% in Q1 2026, buying an estimated $33.1M and bringing the position to 708,717 shares worth $42.6M. The position accounts for 0.09% of the portfolio, ranked #200.

Tidal Investments first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tidal Investments held 708,717 shares of Bristol-Myers Squibb worth $42.6M as of Q1 2026.
  • Tidal Investments bought 567,716 Bristol-Myers Squibb shares in Q1 2026, an estimated $33.1M.
  • Bristol-Myers Squibb made up 0.09% of Tidal Investments's portfolio in Q1 2026, its #200 holding.
  • Tidal Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.